Curated News
By: NewsRamp Editorial Staff
November 12, 2026
Earth Science Tech's Vertical Integration Drives 57% Q1 Net Income Growth
TLDR
- Earth Science Tech gains margin advantage by in-housing compounding, telemedicine, and API supply via Zoolzy, boosting Q1 2026 net income 57%.
- Earth Science Tech integrates compounding pharmacies, telemedicine, clinical support, and Zoolzy's API distribution to control its healthcare supply chain and capture outside margins.
- Earth Science Tech's vertically integrated platform streamlines patient care from consultation to fulfillment, aiming to make healthcare more accessible and efficient.
- Earth Science Tech's diversified model spans pharmacies, telemedicine, real estate, and consumer products, with Q1 2026 operating cash flow up 108%.
Impact - Why it Matters
Earth Science Tech’s ability to grow net income by 57% and operating cash flow by 108% while keeping all key subsidiaries profitable demonstrates the power of vertical integration in healthcare. By owning compounding pharmacies, telemedicine, fulfillment, and now a wholesale distributor of active pharmaceutical ingredients and FDA-approved prescription products through Zoolzy LLC, the company captures margins typically lost to third parties and reduces risk. This matters because it shows a scalable model that could lower costs and improve patient care, while also offering investors a diversified play across healthcare, real estate, and consumer products. The strong fiscal Q1 2026 results suggest the strategy is working, potentially paving the way for sustained growth and resilience.
Summary
Earth Science Tech (OTCQB: ETST) is executing a diversified conglomerate strategy to build a vertically integrated healthcare platform while expanding into real estate, asset management, and consumer products. The company’s healthcare operations combine compounding pharmacies, telemedicine, clinical support, and direct-to-patient fulfillment, all supported by internal technology, proprietary physician networks, and owned real estate. A key move is the acquisition of Zoolzy LLC, a wholesale distributor of active pharmaceutical ingredients and FDA-approved prescription products, which strengthens supply chain control and gives its pharmacies access to competitively priced ingredients. By bringing more functions in-house and leveraging subsidiary capabilities, Earth Science Tech aims to capture margins otherwise paid to outside providers and reduce exposure to individual sector risks. This strategy is reflected in its fiscal first-quarter 2026 results: net income rose 57% year over year, net cash provided by operating activities increased 108%, and all key operating subsidiaries remained profitable. The company’s core value proposition is the seamless integration of patient care from consultation to fulfillment, achieved through specialized subsidiaries. For more details, visit https://nnw.fm/fGJ32 or www.EarthScienceTech.com. The latest updates are available in the company’s newsroom at https://nnw.fm/ETST. This release is distributed by NetworkNewsWire, a specialized communications platform within the Dynamic Brand Portfolio @ IBN, which offers wire solutions via InvestorWire, editorial syndication to 5,000+ outlets, press release enhancement, social media distribution, and corporate communications solutions.
Source Statement
This curated news summary relied on content distributed by InvestorBrandNetwork (IBN). Read the original source here, Earth Science Tech's Vertical Integration Drives 57% Q1 Net Income Growth
